RBOT Stock Analysis: Buy, Sell, or Hold?
RBOT - Vicarious Surgical Inc.
$1.92
-0.12 (-5.88%)
▼
5d:
-10.7%
30d:
-7.69%
90d:
-28.62%
WAIT
LOW Confidence
Analysis Updated: Mar 2, 2026 12:00 AM ET
Earnings: Mar 16, 2026
0d
Get Alerted When RBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: RBOT is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: RBOT is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: RBOT is currently trading at $1.92, which is considered oversold relative to its 30-day fair value range of $1.97 to $2.17.
Technical Outlook: Technically, RBOT is in a strong downtrend. Immediate support is located at $1.75, while resistance sits at $2.41. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: RBOT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+160.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RBOT is in a strong downtrend. Immediate support is located at $1.75, while resistance sits at $2.41. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: RBOT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+160.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.97 -
$2.17
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.9%)
- BULLISH: Trading 160.4% below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -10.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.97 -
$2.17
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.75
Resistance Level
$2.41
Current Trend
Strong Downtrend
Technical data as of
Mar 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$5.00
(+160.4%)
Share & Embed Analysis
Last updated: March 31, 2026 5:35 AM ET
Data refreshes hourly during market hours. Next update: 6:35 AM
Data refreshes hourly during market hours. Next update: 6:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Sammy Khalifa
SELL
239 shares
2025-12-03
Adam David Sachs
SELL
463 shares
2025-12-03
Adam David Sachs
SELL
816 shares
2025-11-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 51 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
